equityflowunderstand the flow and follow it
EquityFlow › Companies › Phagos

Phagos

Biotech · FR

AI-driven personalized phage therapies against antibiotic resistance, starting with animal health.

In the network

Shares the most investors with (number = shared investors):
FabricNano 2

Funding history

DateRoundAmount
Oct 2025Series A
Phagos raised a €25 million Series A co-led by CapAgro, Hoxton Ventures, CapHorn and Demeter.
$29M

Investors

Tap an investor to see what else they have backed.

Acurio VenturesCapHornCapagroCitizen CapitalDemeterEntrepreneur FirstFounders CapitalHoxton VenturesStation F

Other companies in Biotech

ImperagenHaga BiosciencePixelgen TechnologiesGallantChai DiscoverySNIPR BiomeCellbox LabsScope BiosciencesGenLuminaActitheraNUCLIDIUMAnocca

Other companies in FR

CardNexusMendoUncovrAlta AresInnovafeedInnovorderQuoblyMokNWandercraftArlequin AIKoletFungu'it

Other companies at Series A stage

&Done&Open011h01Health1000 Satellites100ms11x.ai12 Pharmacy180° Seguros1X Technologies1k Kirana Bazaar207
Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.